VENUSCANCER SIGNED
Women’s cancers: do variations in patterns of care explain the world-wide inequalities in survival and avoidable premature deaths?
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0VENUSCANCER project word cloud
Explore the words cloud of the VENUSCANCER project. It provides you a very rough idea of what is the project "VENUSCANCER" about.
Project "VENUSCANCER" data sheet
The following table provides information about the project.
| Coordinator |
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
Organization address contact info |
| Coordinator Country | United Kingdom [UK] |
| Total cost | 1˙996˙483 € |
| EC max contribution | 1˙996˙483 € (100%) |
| Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
| Code Call | ERC-2017-COG |
| Funding Scheme | ERC-COG |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-05-01 to 2023-04-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER | UK (LONDON) | coordinator | 1˙996˙483.00 |
Map
Project objective
Opening the World Cancer Congress in Paris in November 2016, President François Hollande insisted that women should be at the heart of cancer control, “because they are victims of inequality in access to prevention, treatment and screening in every country in the world.”
Breast, ovarian and cervical cancers are a major public health problem world-wide. Each year, approximately 2.5 million women are diagnosed with one of these cancers, and 900,000 women die from them, mainly in low- and middle-income countries.
The CONCORD programme for global surveillance of cancer survival reported striking differences in survival from these three cancers. Population-based cancer survival is a key measure of the overall effectiveness of health systems in dealing with cancer, from early diagnosis to comprehensive investigation and optimal treatment. I will exploit the CONCORD data base, as follows:
• Access primary medical records in selected high- and low-income countries to collect more detailed data on stage at diagnosis, staging investigations, morphology, grade, prognostic bio-markers and treatment, for the most recent year during 2010-2014 for which data are available • Analyse the distributions of stage and treatment (“patterns of care”) • Estimate 1- and 5-year survival trends by stage, histological group and/or molecular subtype • Quantify inequalities in survival as the number of premature deaths that would be avoidable if survival in a given country (region) were equal to that in a neighbouring country with higher survival.
This ground-breaking work will show that it is possible (a) to collect high-quality, complete clinical information at population level even in low- and middle-income countries; (b) to explain the striking inequalities in women’s cancer survival world-wide, and (c) to summarise these inequalities in a single number (avoidable deaths) as a powerful tool that motivates policymakers to reduce inequalities in survival.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VENUSCANCER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "VENUSCANCER" are provided by the European Opendata Portal: CORDIS opendata.